Correction: A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment

Daniel Ryan; Abhilasha Sinha; Danielle Bogan; Joanna Davies; Jim Koziol; Wael M. ElShamy

doi:10.18632/oncotarget.23573

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment

PDF | How to cite

Oncotarget. 2017; 8:113294-113294. https://doi.org/10.18632/oncotarget.23573

Metrics: PDF 2943 views | ?

Daniel Ryan^1,*, Abilasha Sinha^2,*, Danielle Bogan^2,*, Joanna Davies¹, Jim Koziol³ and Wael M. ElShamy¹

¹ Breast Cancer Program, San Diego Biomedical Research Institute, San Diego, CA, USA
² University of Mississippi Medical Center, Jackson, MS, USA
³ Department of Molecular and Experimental Medicine, Scripps Research Institute, San Diego, CA, USA
^* These authors have contributed equally to this work

Published: December 22, 2017

This article has been corrected: Dr. Sinha has been added in the author list with an equal contribution note along with Dr. Ryan and Dr. Bogan.

Original article: Oncotarget. 2017; 8:103182-103206. DOI: https://doi.org/10.18632/oncotarget.20892.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 23573

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: A niche that triggers aggressiveness within BRCA1-IRIS overexpressing triple negative tumors is supported by reciprocal interactions with the microenvironment